A mixed bag of Phase III results for using olanzapine with moderately emegotenic chemotherapy (MEC).
Inui, et al: https://doi.org/10.1200/JCO.24.00278
Ostwal, et al: doi:10.1001/jamanetworkopen.2024.26076
